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ABSTRACT
Background:
Establish protocols to enhance the surgical management (ERAS) can improve outcomes, 
shortening hospital stay and save resources. 
Several studies have carried out for colorectal surgery, while a lack of evidence for 
gastrectomy remains.
This study aims to evaluate the impact of ERAS strategies in a large series of patients 
underwent gastric cancer surgery.
Methods:
This is a propensity score-matched case-control study, comparing an ERAS group with 
a control group. Data were recorded through a tailored and protected web-based system. 
Primary outcomes: hospital stay, complications rate. Among the secondary outcomes, 
there are: POD of mobilization, POD of starting liquid diet and soft solid diet.
Results:
Patients in the ERAS and control groups were 1:1 matched by the closest propensity 
score on the logit scale and with a Caliber = 0.2. The successful matching resulted in a 
total sample of 440 patients.
The two groups showed no differences in all baseline patients characteristics, type of 
surgery (P=0.31) and stage of the disease (P=0.61).
A benefit in favor of the ERAS management was found in the length of hospital stay 
(P=0.0004) and complications rate (P=0.001).
Conclusion:
An ERAS program can safely be established in referral centers for gastric cancer, 
enabling to significantly improve the main clinical outcomes.
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Background
Gastric cancer is the second leading cause of cancer 
death in the world and surgery plays the most important 
role in the treatment of this disease.
However, surgery for gastric cancer remains a high-
risk procedure with clinically significant postoperative 
stress, complications, and significant sequelae.
Significant advances in the management of surgical 
patients have been in last decades for gastric cancer. 
This has led to the concept of enhanced recovery after 
surgery (ERAS) with the objective of reducing the length 
of hospital stay accelerating postoperative recovery and 
reducing surgical stress. 
The ERAS protocols have many items, including the pre-
operative patient education, preoperative carbohydrate 
loading, early mobilization and feeding starting from 
the first postoperative days.
Most of studies on this field were published for 
colorectal surgery, while only few authors described 
ERAS protocols in gastric cancer surgery. 
In the present study, we have evaluated the effects 
on postoperative functional recovery outcomes after 
gastrectomy in patients undergoing an ERAS program in 
comparison with a conventional surgical management.
Methods
Type of Study
This is a multi-institutional propensity score-matched 
case-control study, comparing patients undergoing a 
perioperative management based on the ERAS society 
principles (Table 1) and control patients undergoing 
conventional surgical management. 
Data were collected in the context of the IMIGASTRIC 
study and after sharing a specific study protocol.[1]
The study was registered at clinical trials.gov with a 
registration number of NCT02325453.
Table 1: ERAS management.
Time Period and Sites
Data entered into the IMIGASTRIC registry regarding 
procedures performed until data extraction (November 
2019) were analyzed. All involved centers are referral 
institutions with a well-established gastric cancer 
program. All diagnostic and surgical interventions 
at these centers were done according to international 
guidelines and information stored in institutional 
prospective data collection systems.
Inclusion criteria
• Histologically proven gastric cancer
• Preoperative staging work-up performed by upper 
endoscopy and/or endoscopic ultrasound, and CT 
scan and in accordance to international guidelines
• Early Gastric Cancer[2, 3]
• Advanced Gastric Cancer[2, 3]
• Patients treated with curative intent in accordance 
to international guidelines[4, 5]
Exclusion criteria
• Distant metastases: peritoneal carcinomatosis, 
liver metastases, distant lymph node metastases, 
Krukenberg tumors, involvement of other organs
• Patients with high operative risk as defined by the 
American Society of Anesthesiologists (ASA) score 
> 4
• History of previous abdominal surgery for gastric 
cancer
• Synchronous malignancy in other organs
• Palliative surgery
Data Collection and Reported Outcomes
This study reported descriptive findings and outcomes 
among the two groups. Basic patient characteristics, 
tumor findings, and surgical procedure details were 
reported. The outcomes section offers a comparison 
regarding operative results, postoperative recovery, and 
complications.
Source of Data Analyzed
Data gathered were obtained from existing records, 
diagnostic tests, and surgical intervention descriptions. 
Data were collected and recorded by all institutions 
through a specific online shared protected system 
(https://imigastric.logix-software.it/).
The present study was reported in accordance with the 
STROBE guidelines and statement[6]. 
Propensity Score Matching
Propensity score matching analysis was carried out 
using SPSS software version 23 and R software version 
3.1, through the Custom Dialog “PS Matching”. 
Each patient’s propensity score was calculated by 
a multivariable logistic regression model using the 
covariates of institution, age, sex, comorbidities, body 
mass index (BMI), surgical approach (open, laparoscopic, 
robotic) type of gastrectomy, stage of disease.
Patients in the ERAS and Control group were 1:1 
matched by the closest propensity score on the logit 
scale and with a Caliper = 0.2
Statistics
IBM SPSS Statistics V.23 was used to carry out the 
statistical analysis. An intention to treat analysis was 
performed.
The dichotomous variables were expressed as numbers 
and percentages, while continuous variables as mean 
and SD, or median and IQR (minimum and maximum 
values). Continuous variables were compared using 
independent T test.
Pearson’s χ2 test or Fisher’s exact test, as appropriate, 
was used for analysis of categorical data. A P value of 
Giovanardi F, et al./ JGS 2 (2020) 
doi: 10.36159/jgs.v2i4.63 
www.journalofgastricsurgery.com
<0.05 was considered statistically significant.
Results
At the time of this analysis, 1445 patients entered in the 
IMIGASTRIC registry had information on the ERAS 
management. 
The matching analysis resulted in a total sample of 
440 patients, 220 from the ERAS group and 220 from 
the Control group. The successful matching permitted 
to obtain a homogeneous distribution of all patient’s 
characteristics (Table 2).
Table 3 shows no significant differences between groups 
in surgical approach (P=0.14), type of gastrectomy 
(P=0.31), stage of the disease (P=0.61).
A significantly shorter hospital stay (P=0.0004; Figure 1) 
was found in the ERAS group versus the Control group 
(Table 4).
The most relevant benefit was shown in the resumption 
of a liquid (P=0.01; Figure 2) and a soft solid diet (P=0.007; 
Figure 3). 
No significant differences in patient mobilization 
(P=0.56) and first flatus (P=0.07) were found.
The ERAS group showed some advantages in the 
intravenous analgesic use (P<0.0001; Figure 4) than the 
control group, but no differences were found in the 
length of antibiotic use (P=0.31).
In this study the adoption of an ERAS protocol resulted 
in a significant reduction in post-operative complications 
(P=0.001) than the Control group.
Table 2: Basic patients’ characteristics.
Table 3: Surgical and pathological characteristics.
Table 4: perioperative outcomes.
Figure 1: mean difference between groups in the length of 
hospital stay.
Figure 2: mean difference between groups in starting a liquid 
intake.
Figure 3: mean difference between groups in starting a soft 
solid diet.
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Figure 4: mean difference between groups in the length of 
intravenous analgesic use.
Discussion
The present study evaluated the role of the ERAS program 
in the management of gastric cancer patients using a 
propensity score case matched analysis to perform a 
comparison with a conventional care treatment. 
A significant decrease in the length of hospital stay and 
in-hospital postoperative complications were the most 
relevant findings.
Important items in the ERAS protocol are early 
mobilization and feeding[7], which is especially facilitated 
by the absence of the NG tube and drainage, as well as 
an early removal of the urinary catheter. Smart[8] showed 
that failure of early patient mobilization is associated with 
prolonged hospital stay.
Yamada[9] in his study showed that the recovery of bowel 
function was significantly earlier in the ERAS group than 
in the conventional group.
In addition, Wang[10] reported that the first day of 
flatulence after gastric surgery was a mean of one day 
earlier in patients who received fast-track surgery 
compared to those who received conventional care.
Some factors such as prolonged fasting and placement of 
the nasogastric tube appear to cause nausea and contribute 
to a delay of intestinal recovery[11].
In our study, there was not a significant difference 
regarding the first flatus. However, we believe that 
this outcome is subject to a high risk of bias. Instead, 
variables regarding the oral recovery of food intake can be 
considered more reliable.
We found a significant advantage in favor of the ERAS 
group in all steps of food intake, from starting a liquid diet 
(3.89±2.7 vs 4.76±4.41; P<0.01) to the resumption of a solid 
diet (6.79±4.91 vs 9.05±10.87; P=0.007).
The ERAS protocols require the patient be not subjected to 
long periods of fasting.
Early postoperative nutrition reduces postoperative 
catabolism, accelerates the return of bowel function, and 
decreases the risk of complications. This was especially 
studied in colorectal surgery[12, 13].
Moreover, Lewis et al.[14] confirmed in their meta-analysis 
that keeping patients in a fasting state is not beneficial.
Several studies have shown that early oral feeding is 
feasible and brings benefits in gastric surgery[10, 15]; 
however, this point remains controversial.
Even if an early postoperative oral feeding has been shown 
to speed up the recovery after various types of surgery, 
this approach after gastrectomy has always been seen 
with suspicion because of some concerns, not actually well 
demonstrated in the literature, that early food intake may 
cause anastomotic leakage or intestinal obstruction.
In recent years, several studies have confirmed that early 
oral food intake after gastric surgery is safe and might be 
associated with enhanced recovery and shorter hospital 
stay[9, 16].
Particularly, a randomized controlled study has reported 
data on the safety of early oral feeding starting in the 
second postoperative day (POD 2) after gastrectomy[17].
The Makuuchi[18] and Pedziwiatr[19] studies, comparing 
ERAS and conventional management after gastrectomy, 
have confirmed that oral feeding in POD 2 is safe and 
allows the reduction of post-operative administration of 
intravenous fluids and an early discharge[20].
Sugisawa[21] focused on the rate of anastomotic leakage 
and aspiration pneumonia to evaluate the real risks of 
early nutrition.
In his study, the incidence of anastomotic leakage was 0.8%, 
a figure he highlighted as not only lower than that of the 
subjects in his historical cohort (1.7%), but also a result not 
different or lower (0.8-1.9%) when compared to previous 
data in studies in which conventional perioperative care 
was reported. Therefore, the author concluded that early 
oral nutrition is not able to adversely affect the anastomotic 
site. The same results were obtained by Yamada[9, 22], 
showing a similar incidence in anastomotic leaks (1.1%).
In our study, the adoption of an ERAS program resulted 
in a significant reduction in hospital stay with a mean 
difference of 3.42 days compared to conventional 
management.
Similar results were obtained by Sugisawa[21] and 
Wang[10].
In our study, a significant reduction in patients with 
postoperative complications (8.2% versus 19.5%; P=0.001) 
was shown in the ERAS group. Moreover, no differences 
in readmissions for complications after discharge were 
shown (P=0.5).
In conclusion, the adoption of a management based on the 
ERAS principles for gastric cancer can safely improve the 
patient’s functional recovery, allowing an early discharge 
and a reduction of overall complications.
Acknowledgements
None 
Contributors
FG, FF, CC, MC, MP conceptualized and designed the 
study, acquired, and analyzed data, interpreted the study 
results, drafted the manuscript, and critically revised the 
final version of the manuscript.
Funding
This study received financial support for data extraction 
and analysis in the context of the Research Startup Projects 
(2019) granted by “La Sapienza” University of Rome.
Competing interests
No benefits in any form have been received or will be 
received from a commercial party related directly or 
indirectly to the subject of this article.
Giovanardi F, et al./ JGS 2 (2020) 
doi: 10.36159/jgs.v2i4.63 
www.journalofgastricsurgery.com
Availability of data and materials
Further information is available from the corresponding 
author on reasonable request.
Ethics approval 
This study is conducted in compliance with ethical 
principles originating from the Helsinki Declaration, 
within the guidelines of Good Clinical Practice and 
relevant laws/regulations. Trial registration number: 
NCT02325453.
Provenance and peer review 
Not commissioned; externally peer reviewed. 
Open access
This is an Open Access article distributed in accordance 
with the Creative Commons Attribution Non-Commercial 
(CC BY-NC 4.0) license, which permits others to distribute, 
remix, adapt, build upon this work noncommercially, and 
license their derivative works on different terms, provided 
the original work is properly cited and the use is non-
commercial. See: http://creativecommons.org/licenses/
by-nc/4.0/
References
[1] Desiderio J, Jiang ZW, Nguyen NT, Zhang S, Reim D, Alimoglu O, et 
al. Robotic, laparoscopic and open surgery for gastric cancer compared 
on surgical, clinical and oncological outcomes: a multi-institutional 
chart review. A study protocol of the International study group on 
Minimally Invasive surgery for GASTRIc Cancer-IMIGASTRIC. BMJ 
open. 2015;5:e008198.
[2] Japanese classification of gastric carcinoma: 3rd English edition. 
Gastric Cancer. 2011;14:101-12.
[3] Murakami T. Pathomorphological diagnosis. Definition and gross 
classification of early gastric cancer. Gann Monogr Cancer Res. 1971:53-5.
[4] Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric 
Cancer. 2011;14:113-23.
[5] Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold 
D. Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines 
for diagnosis, treatment and follow-up. European journal of surgical 
oncology : the journal of the European Society of Surgical Oncology and 
the British Association of Surgical Oncology. 2014;40:584-91.
[6] von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, 
Vandenbroucke JP, et al. The Strengthening the Reporting of 
Observational Studies in Epidemiology (STROBE) Statement: guidelines 
for reporting observational studies. International journal of surgery. 
2014;12:1495-9.
[7] Vlug MS, Wind J, Hollmann MW, Ubbink DT, Cense HA, Engel AF, et 
al. Laparoscopy in combination with fast track multimodal management 
is the best perioperative strategy in patients undergoing colonic surgery: 
a randomized clinical trial (LAFA-study). Ann Surg. 2011;254:868-75.
[8] Smart NJ, White P, Allison AS, Ockrim JB, Kennedy RH, Francis 
NK. Deviation and failure of enhanced recovery after surgery following 
laparoscopic colorectal surgery: early prediction model. Colorectal 
disease : the official journal of the Association of Coloproctology of Great 
Britain and Ireland. 2012;14:e727-34.
[9] Yamada T, Hayashi T, Cho H, Yoshikawa T, Taniguchi H, Fukushima 
R, et al. Usefulness of enhanced recovery after surgery protocol as 
compared with conventional perioperative care in gastric surgery. 
Gastric Cancer. 2012;15:34-41.
[10] Wang D, Kong Y, Zhong B, Zhou X, Zhou Y. Fast-track surgery 
improves postoperative recovery in patients with gastric cancer: a 
randomized comparison with conventional postoperative care. Journal 
of gastrointestinal surgery : official journal of the Society for Surgery of 
the Alimentary Tract. 2010;14:620-7.
[11] Teeuwen PH, Bleichrodt RP, Strik C, Groenewoud JJ, Brinkert 
W, van Laarhoven CJ, et al. Enhanced recovery after surgery (ERAS) 
versus conventional postoperative care in colorectal surgery. Journal of 
gastrointestinal surgery : official journal of the Society for Surgery of the 
Alimentary Tract. 2010;14:88-95.
[12] Lewis SJ, Egger M, Sylvester PA, Thomas S. Early enteral feeding 
versus “nil by mouth” after gastrointestinal surgery: systematic review 
and meta-analysis of controlled trials. Bmj. 2001;323:773-6.
[13] Han-Geurts IJ, Hop WC, Kok NF, Lim A, Brouwer KJ, Jeekel J. 
Randomized clinical trial of the impact of early enteral feeding on 
postoperative ileus and recovery. The British journal of surgery. 
2007;94:555-61.
[14] Lewis SJ, Andersen HK, Thomas S. Early enteral nutrition within 24 h 
of intestinal surgery versus later commencement of feeding: a systematic 
review and meta-analysis. Journal of gastrointestinal surgery : official 
journal of the Society for Surgery of the Alimentary Tract. 2009;13:569-75.
[15] Jo DH, Jeong O, Sun JW, Jeong MR, Ryu SY, Park YK. Feasibility 
study of early oral intake after gastrectomy for gastric carcinoma. Journal 
of gastric cancer. 2011;11:101-8.
[16] Scatizzi M, Kroning KC, Boddi V, De Prizio M, Feroci F. Fast-track 
surgery after laparoscopic colorectal surgery: is it feasible in a general 
surgery unit? Surgery. 2010;147:219-26.
[17] Hur H, Kim SG, Shim JH, Song KY, Kim W, Park CH, et al. Effect 
of early oral feeding after gastric cancer surgery: a result of randomized 
clinical trial. Surgery. 2011;149:561-8.
[18] Makuuchi R, Sugisawa N, Kaji S, Hikage M, Tokunaga M, Tanizawa 
Y, et al. Enhanced recovery after surgery for gastric cancer and an 
assessment of preoperative carbohydrate loading. Eur J Surg Oncol. 2016.
[19] Pedziwiatr M, Matlok M, Kisialeuski M, Migaczewski M, Major P, 
Winiarski M, et al. Short hospital stays after laparoscopic gastric surgery 
under an Enhanced Recovery After Surgery (ERAS) pathway: experience 
at a single center. European surgery : ACA : Acta chirurgica Austriaca. 
2014;46:128-32.
[20] Terashima M. The earlier the better? Gastric Cancer. 2014;17:197-9.
[21] Sugisawa N, Tokunaga M, Makuuchi R, Miki Y, Tanizawa Y, Bando 
E, et al. A phase II study of an enhanced recovery after surgery protocol 
in gastric cancer surgery. Gastric Cancer. 2016;19:961-7.
[22] Yamada T, Hayashi T, Aoyama T, Shirai J, Fujikawa H, Cho H, et 
al. Feasibility of enhanced recovery after surgery in gastric surgery: a 
retrospective study. BMC surgery. 2014;14:41.
Giovanardi F, et al./ JGS 2 (2020) 
doi: 10.36159/jgs.v2i4.63 
